Century Therapeutics Inc (IPSC) — Capital Reinvestment Ratio
Century Therapeutics Inc (IPSC) has a Capital Reinvestment Ratio of 0.05x as of March 2022, meaning it reinvests 0% of its operating cash flow ($86.75 Million) in capital expenditures ($4.07 Million). See Century Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Century Therapeutics Inc Capital Reinvestment Ratio (2015–2022)
This chart tracks Century Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check how aggressively does Century Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Century Therapeutics Inc (2015–2022)
Year-by-year Capital Reinvestment Ratio for Century Therapeutics Inc from 2015 to 2022. For live market cap and broader valuation context, see Century Therapeutics Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.18x | $14.05 Million | $30.60 Million | ▲ +672.7% |
| 2015 | 0.28x | $104.30 Million | $29.39 Million | — |